Listerine Category I status for safety, efficacy recommended by FDA plaque subcmte.
This article was originally published in The Tan Sheet
Executive Summary
LISTERINE CATEGORY I STATUS FOR SAFETY, EFFICACY RECOMMENDED by FDA's Dental Products Panel Plaque Subcommittee at its Oct. 29-30 meeting in Gaithersburg, Md. The subcommittee agreed unanimously that the active ingredient combination of essential oils in Warner-Lambert's Listerine -- .064% thymol, .042% menthol, .092% eucalyptol and .06% menthol salicylate -- should be included in the OTC oral health care products monograph as a safe and effective treatment for plaque and gingivitis.